TY  - JOUR

T1  - A review of perspectives on the use of randomization in phase II oncology trials

JO  - JNCI: Journal of the National Cancer Institute

UR  - http://eprints.whiterose.ac.uk/148314/

PY  - 2019/06/20

AU  - Grayling MJ

AU  - Dimairo M

AU  - Mander AP

AU  - Jaki TF

ED  - 

DO  - DOI: 10.1093/jnci/djz126

PB  - Oxford University Press (OUP)

Y2  - 2024/09/20

ER  -